ELOSITY
Live / Registered — Registered (as of 27 Jan 2026)
What this means for you
Registered since 27 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97980427
- Registration number
- 8119032
- Mark type
- Design + words
- Filed
- 09 Dec 2022
- Published for opposition
- 19 Mar 2024
- Registered
- 27 Jan 2026
- Attorney of record
- Tore T. DeBella
Goods and services
- Class 042 — Scientific and technological services: Providing online non-downloadable software for managing trial sites, inventory of clinical trial supplies, studies, randomization of clinical trial participants, supply chain, drug supplies, reporting, and electronic data reconciliation in connection with clinical trials; providing online non-downloadable software for collecting, storing, processing, managing, and reporting on clinical trial data
Owner
- ENDPOINT CLINICAL L.P., RALEIGH, NC, US
- ENDPOINT CLINICAL L.P., RALEIGH, NC, US
- ENDPOINT CLINICAL INC., DURHAM, NC, US
- ENDPOINT CLINICAL INC., DURHAM, NC, US
- Labcorp Endpoint Clinical Inc., Wakefield, MA, US
Prosecution history
- 27 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 06 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Nov 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Nov 2025 — ASSIGNED TO LIE
- 10 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Sept 2025 — NON-FINAL ACTION E-MAILED
- 26 Sept 2025 — SU - NON-FINAL ACTION - WRITTEN
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Apr 2025 — USE AMENDMENT FILED